Literature DB >> 10650496

[Guidelines on antimicrobial therapy of pneumonia in Taiwan. The Infectious Diseases Society of the Republic of China].

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10650496

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN： 1684-1182            Impact factor:   4.399


× No keyword cloud information.
  4 in total

1.  Emergence of fluoroquinolone resistance in group B streptococcal isolates in Taiwan.

Authors:  Hsiu-Mei Wu; Rajendra Prasad Janapatla; Yueh-Ren Ho; Kuei-Hsiang Hung; Chi-Wen Wu; Jing-Jou Yan; Jiunn-Jong Wu
Journal:  Antimicrob Agents Chemother       Date:  2008-02-25       Impact factor: 5.191

2.  Telithromycin- and fluoroquinolone-resistant Streptococcus pneumoniae in Taiwan with high prevalence of resistance to macrolides and beta-lactams: SMART program 2001 data.

Authors:  Po-Ren Hsueh; Lee-Jene Teng; Tsu-Lan Wu; Dine Yang; Wen-Kuei Huang; Jainn-Ming Shyr; Yin-Ching Chuang; Jen-Hsien Wan; Jing-Jou Yan; Jang-Jih Lu; Jiunn-Jong Wu; Wen-Chien Ko; Feng-Yee Chang; Yi-Chueh Yang; Yeu-Jun Lau; Yung-Ching Liu; Chun-Ming Lee; Hsieh-Shong Leu; Cheng-Yi Liu; Kwen-Tay Luh
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

3.  Fatal septicemic melioidosis in a young military person possibly co-infected with Leptospira interrogans and Orientia tsutsugamushi.

Authors:  Po-Liang Lu; Shu-Hui Tseng
Journal:  Kaohsiung J Med Sci       Date:  2005-04       Impact factor: 2.744

4.  Antimicrobial resistance in Streptococcus pneumoniae, Taiwan.

Authors:  Po-Ren Hsueh; Kwen-Tay Luh
Journal:  Emerg Infect Dis       Date:  2002-12       Impact factor: 6.883
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.